# An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP

> **NCT03707353** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 43 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** ChAd63 ME-TRAP and MVA ME-TRAP vaccination

## Key facts

- **NCT ID:** NCT03707353
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-06-10
- **Final completion:** 2019-06-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707353, "An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03707353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*